Tag archives: medtech

Narwhals, unicorns and profits – Canadian tech start-ups are on the rise

By Troy Ungerman (Toronto) on March 28, 2019 Posted in M&A, Technology and innovation

Unicorns and narwhals – what business do these creatures have in boardrooms and on stock exchanges? “Unicorn” and “narwhal” are industry terms used to describe certain private start-up tech companies. “Unicorns” are start-ups valued by investors at $1B or more, a rare and substantial feat that has earned them their mythical nickname. “Narwhals” sit a … Continue reading

Dissecting MedTech M&A deals

By Shreya Gupta (Toronto) on November 20, 2018 Posted in M&A, Pharmaceuticals and life sciences

As we previously reported, this year has seen a surge in healthcare-related M&A. Many of these transactions are in the medical technology industry, or MedTech. While the industry’s healthy profit margins and opportunities for growth have driven a flurry of activity, the potential for large rewards from MedTech acquisitions also comes with unique obstacles: Regulatory compliance: … Continue reading